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Role of Arg-401 of cytosolic serine hydroxymethyltransferase in subunit
assembly and interaction with the substrate carboxy group
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Department of Biochemistry, Indian Institute of Science, Bangalore-560 012, India
In an attempt to identify the arginine residue involved in binding
of the carboxylate group of serine to mammalian serine hydroxy-
methyltransferase, a highly conserved Arg-401 was mutated to
Ala by site-directed mutagenesis. The mutant enzyme had a
characteristic visible absorbance at 425 nm indicative of the
presence of bound pyridoxal 5«-phosphate as an internal aldimine
with a lysine residue. However, it had only 0.003% of the
catalytic activity of the wild-type enzyme. It was also unable to
perform reactions with glycine, b-phenylserine or d-alanine,
suggesting that the binding of these substrates to the mutant
enzyme was affected. This was also evident from the interaction
of amino-oxyacetic acid, which was very slow (8.4¬10−% s−" at
50 lM) for the R401A mutant enzyme compared with the wild-
type enzyme (44.6 s−" at 50 lM). In contrast, methoxyamine
(which lacks the carboxy group) reacted with the mutant enzyme
(1.72 s−" at 250 lM) more rapidly than the wild-type enzyme
(0.2 s−" at 250 lM). Further, both wild-type and the mutant
enzymeswere capable of forming unique quinonoid intermediates
INTRODUCTION
Serine hydroxymethyltransferase (SHMT; EC 2.1.2.1) catalyses
the reversible conversion of serine and 5,6,7,8-tetrahydrofolate
(H
%
-folate) to glycine and 5,10-methylene-H
%
-folate. This enzyme
has an important role in one-carbon metabolism, providing the
cell with approx. 70% of the one-carbon units required for
the synthesis of thymidine, purines, choline and methionine, for
example [1]. It has been shown that the incorporation of the b-
carbon of serine into DNA via the SHMT reaction increases
when cells are stimulated to proliferate during the S-phase of the
cell cycle [2,3]. Further, SHMT activity is elevated in a variety of
tumour tissues [4,5]. It has therefore attracted widespread at-
tention as a model pyridoxal 5«-phosphate (PLP) protein and a
target for cancer chemotherapy [6].
It has been suggested that the PLP-dependent enzymes have
the same spatial fold as aspartate aminotransferase (AAT), even
though these enzymes have less than 15% sequence identity [7,8].
Pascarella et al. [9] proposed that SHMT also has the same
general spatial fold as AAT, and structural alignment analysis
indicates that Arg-363 of Escherichia coli SHMT is equivalent to
Arg-383 of AAT. Crystal structure and site-directed mutagenesis
studies of AAT reveal that the Arg-383 has a role in binding the
substrate carboxy group and in the conversion of the enzyme
from ‘open’ to the ‘closed’ form [10,11]. Site-directed muta-
genesis studies on E. coli SHMT indicate that this Arg-363
Abbreviations used: AAA, amino-oxyacetic acid ; AAT, aspartate aminotransferase ; H4-folate, 5,6,7,8-tetrahydrofolate ; MA, methoxyamine ; PLP,
pyridoxal 5«-phosphate ; rSHMT, sheep liver cytosolic recombinant SHMT; SHMT, serine hydroxymethyltransferase; TSC, thiosemicarbazide.
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absorbing at 440 and 464 nm on interaction with thiosemi-
carbazide, which also does not have a carboxy group. These
results implicate Arg-401 in the binding of the substrate carboxy
group. In addition, gel-filtration profiles of the apoenzyme and
the reconstituted holoenzyme ofR401Aand thewild-type enzyme
showed that the mutant enzyme remained in a tetrameric form
even when the cofactor had been removed. However, the wild-
type enzyme underwent partial dissociation to a dimer, suggesting
that the oligomeric structure was rendered more stable by the
mutation of Arg-401. The increased stability of the mutant
enzyme was also reflected in the higher apparent melting tem-
perature (T
m
) (61 °C) than that of the wild-type enzyme (56 °C).
The addition of serine or serinamide did not change the apparent
T
m
of R401A mutant enzyme. These results suggest that the
mutant enzyme might be in a permanently ‘open’ form and the
increased apparent T
m
could be due to enhanced subunit
interactions.
residue has a similar functional role in binding the substrate
carboxy group [12].
The mammalian cytosolic SHMTs are tetramers of identical
subunits of 53 kDa with 4 mol of PLP per mol of enzyme [13,14],
unlike the E. coli SHMT, which is a dimer [15]. The sheep liver
cytosolic enzyme has been characterized in our laboratory with
respect to its primary structure [16], catalysis [17,18] and the
interaction of substrate and substrate analogues at the active site
[19–23]. This enzyme has been cloned and overexpressed in E.
coli [24] with the aim of identifying the amino acid residues
involved in subunit and active-site interactions. Alignment of the
amino acid sequence of SHMTs showed that Arg-401 in the
mammalian enzyme was equivalent to Arg-363 in the E. coli
enzyme. Here we report the construction, expression and charac-
terization of the R401A mutant of sheep liver cytosolic recom-
binant SHMT (rSHMT). The results indicate that the carboxy
group of the substrate interacts with Arg-401; in the absence of
this positively charged residue, the subunit interactions are
strengthened.
EXPERIMENTAL
Materials
[a-$#P]dATP (3000 Ci}mmol), l-[3-"%C]serine (55 mCi}mmol),
restriction endonucleases, Sequenase2 version 2.0 DNA se-
quencing kit and DNA-modifying enzymes were obtained from
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Amersham International. CM-Sephadex and Sephacryl S-200
were obtained from Pharmacia Fine Chemicals. Glycine, l-
serine, l-serinamide, d-alanine, amino-oxyacetic acid (AAA),
methoxyamine (MA), thiosemicarbazide (TSC), hydroxylamine,
l-cysteine hydrochloride, b-phenylserine, 2-mercaptoethanol, fo-
lic acid, PLP and EDTA were obtained from Sigma Chemical
Company. H
%
-Folate was prepared by the method of Hatefi
et al. [25]. All other chemicals were of A.R. grade. The mutant
oligonucleotide was purchased from Bangalore Genei Private
Limited (Bangalore, India).
Bacterial strains and growth conditions
E. coli strain DH5a (BRL) was the recipient for all the plasmids
used in subcloning. The BL21(DE3) pLysS strain [26] was used
for the bacterial expression of pETSH and R401A mutant.
Luria–Bertani medium or ‘terrific’ broth with 50 lg}ml of
ampicillin was used for growing E. coli cells containing the
plasmids [27].
DNA manipulations
Plasmids were prepared by the alkaline lysis procedure as
described by Sambrook et al. [27]. Restriction endonuclease
digestions, Klenow filling and ligations were performed in
accordance with the manufacturers’ instructions. The pre-
paration of competent cells and transformation was performed
by the method of Alexander [28]. The DNA fragments were
eluted from the agarose gel by the low-melting agarose gel
method [27].
Site-directed mutagenesis
The R401A mutant was constructed by a PCR-based megaprimer
method, as described previously [29]. The mutant was constructed
from pUCSH (containing the SHMT cDNA fragment lacking
227 bp at the 5« end in pUC 19) as a template. The mutant
oligonucleotide (25-mer) 5«-CCC AGT GGC TTG GCC CTG
GGG ACC C-3« was used for the construction of the R401A
mutant. The full-length PCR product obtained after two rounds
of PCR was subcloned into pUC 19 at KpnI and BamHI sites.
The clones obtained after the mutagenesis procedure were
identified by sequencing the gene at the mutated region. The
pUC 19 plasmid containing the mutated SHMT cDNA was
purified and digested with the PmaCI and BamHI restriction
enzymes flanking the Arg!Ala mutation. The 738 bp PmaCI–
BamHI-mutated DNA fragment was gel-purified and swapped at
the same sites of the pETSH vector [24]. The entire 738 bp
PmaCI–BamHI DNA fragment of the R401A mutant clone was
sequenced with a Sequenase2 version 2.0 DNA sequencing kit to
rule out the presence of other non-specific mutations.
Expression and purification of R401A SHMT
The pETSH and R401A mutant constructs were transformed
into BL21(DE3) pLysS strain. A single colony was inoculated in
50 ml of Luria–Bertani medium containing 50 lg}ml ampicillin
and grown overnight at 37 °C; 4% of these cells grown overnight
were inoculated into 1 litre of ‘ terrific’ broth medium containing
50 lg}ml ampicillin. After 3.5 h of growth at 37 °C, the cells were
induced for 4 h with 0.3 mM isopropyl b-d-thiogalactoside. The
cell pellet was harvested, resuspended in 150 ml of extraction
buffer (50 mM potassium phosphate buffer, pH 7.4, containing
5 mM 2-mercaptoethanol, 1 mM EDTA and 100 lM PLP) and
sonicated until it was optically clear. The supernatant was
subjected to 0–65%-satd. (NH
%
)
#
SO
%
precipitation; the pellet
obtained was resuspended in 20 ml of 20 mM potassium phos-
phate buffer, pH 6.4, containing 1 mM2-mercaptoethanol, 1 mM
EDTA and 50 lM PLP, then dialysed for 24 h against the same
buffer (1 litre with two changes). The dialysed sample was loaded
on a CM-Sephadex column (2 cm¬20 cm) equilibrated with
20 mM potassium phosphate buffer, pH 6.4, containing 1 mM 2-
mercaptoethanol, 1 mM EDTA and 50 lM PLP. The column
was washed with the same buffer (1 litre) and the bound enzyme
was eluted with 100 ml of 200 mM potassium phosphate buffer,
pH 7.4, containing 1 mM 2-mercaptoethanol, 1 mM EDTA and
50 lM PLP. The eluted sample was subjected to 0–65%-satd.
(NH
%
)
#
SO
%
precipitation. The pellet obtained was resuspended in
4 ml of 200 mM potassium phosphate buffer, pH 7.4, containing
1 mM 2-mercaptoethanol, 1 mM EDTA and 50 lM PLP and
subjected to Sephacryl S-200 column chromatography as de-
scribed previously [24]. Fractions containing the enzyme were
pooled and precipitated at 65%-satd. (NH
%
)
#
SO
%
and the pellet
was resuspended in 50 mM potassium phosphate, 1 lM
2-mercaptoethanol and 1 mM EDTA (buffer A) and dialysed
against 1 litre of the same buffer (with two changes) for 24 h;
this enzyme preparation was used in these studies.
Enzyme assay and protein estimation
The aldol cleavage of serine with H
%
-folate to glycine and 5,10-
methylene-H
%
-folate catalysed by SHMT was monitored with
l-[3-"%C]serine and H
%
-folate as substrates [30,31].
Purified rSHMT (1 ml; 10 A
#)!
units}ml) enzyme was passed
through a Centricon filter with 10 ml of doubly distilled water.
After Centricon filtration, the absorbance was measured at
280 nm, then the sample was freeze-dried and weighed. The
concentration at 1 A
#)!
unit was found to be 1.2 mg with a molar
absorption coefficient of 176333 M−"[cm−". A similar value was
obtained when the protein was estimated by the method of Gill
and von Hippel [32]. This value was used for the estimation of
the mutant enzyme because A
#)!
nm did not change compared
with the wild-type enzyme.
Estimation of PLP content
The purified rSHMT and R401A SHMT were dialysed ex-
tensively against buffer A. These dialysed enzyme samples
(1.2 mg}ml) were incubated separately with 0.1 M NaOH for
5 min and the absorbance was measured at 388 nm. The PLP
content was determined, taking the molar absorption coefficient
of PLP in 0.1 M NaOH as 6600 M−"[cm−" at 388 nm [33].
Spectroscopy
The visible spectra were recorded at 25 °C in buffer A with a
Shimadzu UV–visible (UV-160A) spectrophotometer. CD
measurements were made with a JASCO-J-500A automated re-
cording spectropolarimeter. The CD spectra were recorded at
22³2 °C in buffer A, with the same buffer as blank. The protein
concentration corresponding to 0.12 mg}ml was used for far-UV
CD studies. Rapid reaction kinetic studies were performed with
a Biologic Stopped Flow Module with Biokine software for
monitoring the interaction of AAA (50 lM) and MA (250 lM),
with rSHMT (10 lM) and the R401A SHMT (10 lM) mutant at
425 nm. The pseudo-first-order rate constants were calculated by
a curve-fitting analysis of Sigma Plot software by fitting the data
to a first-order rate equation.
Size-exclusion chromatography
To analyse the oligomeric structure of the mutant holoenzyme
and apoenzyme, a Superose-12 HR 10}30 analytical gel-filtration
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column was used on a Pharmacia FPLC system. The column was
calibrated with standard molecular mass markers, i.e. apoferritin
(440 kDa), sheep cytosolic SHMT (213 kDa), yeast alcohol
dehydrogenase (150 kDa), BSA (66 kDa), carbonic anhydrase
(29 kDa) and cytochrome c (12.4 kDa). The buffer used for this
study was buffer A containing 0.1 M KCl and 0.05% sodium
azide. The absorbance was recorded at 280 nm. The holoenzyme
and apoenzyme (100 lg) were analysed immediately after dialysis
as described above. The apoenzymes (100 lg) were reconstituted
by incubation with 100 lM of PLP for 10 min and then analysed
on the gel-filtration column. The percentages of tetramer and
dimer were calculated from the corresponding areas on the
chromatogram.
Apoenzyme preparation
The rSHMT and R401A SHMT (2 mg}ml) in buffer A were
incubated with 50 lM hydroxylamine at 25³2 °C for 30 min.
The sample was subsequently dialysed for 24 h against buffer A
(1 litre with two changes) to remove the PLP-oximes.
Thermal stability
Thermal denaturation of rSHMT and R401A SHMT was
performed in a Gilford Response II spectrophotometer from
Ciba Corning Diagnostics (Oberlin, OH, U.S.A.) as described
by Bhaskar et al. [34], with the following modifications. The
protein samples (300 ll, 0.3 mg}ml ) in buffer A were heated
from 30 to 80 °C at the rate of 1 °C}min. The absorbance change
in each case was monitored at 287 nm and data were averaged
from two experiments. The first derivative of the thermal
denaturation profiles was used to evaluate the apparent transition
temperatures of both proteins. Similar conditions were used to
monitor the thermal denaturation profiles of rSHMT and R401A
SHMT in the presence of serine, glycine, serinamide or alanine at
100 mM concentration, with the buffer blank in the reference
cuvette with the same ligand concentration.
RESULTS
Properties of R401A SHMT
The visible absorption spectra of rSHMT and R401A SHMT
indicated the presence of an internal aldimine in the mutant
enzyme, as in rSHMT. The absorbance values at 425 nm were
0.115 and 0.08 per mg of the mutant and rSHMT respectively.
The increase in absorbance could be caused by either an increased
PLP content or a change in the environment of the active site.
The PLP content of R401A and rSHMT were therefore estimated
as described in the Experimental section. R401A SHMT and
rSHMT contained PLP at 4.1 mol}mol and 3.5 mol}mol
respectively, indicating that a small amount of apoenzyme might
have formed during the isolation of the rSHMT. The secondary
structure of R401A SHMT, as monitored by far-UV CD
(195–250 nm), did not show any alteration in the structure as a
consequence of the mutation. The subunit and native molecular
masses of the mutant enzyme as monitored by SDS}PAGE and
gel filtration analysis confirmed that it was a homotetramer, as is
the wild-type enzyme.
Interaction of substrate analogues
The R401A SHMT was unable to catalyse the hydroxymethyl
transfer from serine. The specific activity of the mutant was only
1.6¬10−% units}mg compared with 4.8 units}mg for rSHMT.
Similarly, it was unable to catalyse the reactions with b-
Figure 1 Interaction of cysteine with rSHMT and R401A
The spectra of rSHMT (0.6 mg/ml) were recorded 0 and 0.5 min after the addition of cysteine
(10 mM) in buffer A. For R401A SHMT (0.6 mg/ml) the spectra were recorded 0, 0.5 and
220 min after the addition of cysteine (10 mM) in buffer A. The reference cuvette contained all
components except enzyme.
phenylserine,d-alanine or glycine.Cysteine, a substrate analogue,
reacts with the internal aldimine of the enzyme to yield a
thiazolidine complex [35]. It can be seen from Figure 1 that the
reaction of cysteine with rSHMT was complete within 30 s, as
indicated by the disappearance of 425 nm absorbance and the
concomitant appearance of a 330 nm peak. In contrast, the
absorbance changes (at 425 and 330 nm) with the R401A SHMT
were very slow and even after 4 h the reaction was not complete,
suggesting that the absence of Arg-401 had affected the in-
teraction of cysteine with the enzyme.
We had earlier shown that amino-oxy compounds such as O-
amino-d-serine and AAA reacted more efficiently with the
enzyme than MA, which lacks the carboxy group; the presence
of a carboxy group had a profound influence on the rate of
reaction [20–22]. These compounds were used to probe the role
of the Arg-401 residue in the interaction of the carboxy group of
ligands. It can be seen from Figure 2 that AAA reacts rapidly
with rSHMT to yield the oxime with the formation of an
intermediate absorbing at 388 nm with an isosbestic point at
376 nm. In contrast, AAA reacted very slowly with R401A
SHMT and yielded the oxime without the formation of an
intermediate absorbing at 388 nm. MA, which lacks the carboxy
group, reacts with rSHMT and the mutant enzyme (Figure 3) in
a similar manner to yield the oxime with an intermediate
absorbing at 388 nm and an isosbestic point at 364 nm.
The rate constants for the interaction of AAA with rSHMT
and of MA with rSHMT and the mutant enzyme were determined
by rapid reaction kinetics because the rate of disappearance at
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Figure 2 Interaction of AAA with rSHMT and R401A SHMT
The spectra of rSHMT (1 mg/ml) were recorded 0, 0.5 and 30 min after the addition of AAA
(50 lM) in buffer A. For R401A SHMT (1 mg/ml), the spectra were recorded 0, 0.5 and 30 min
after the addition of AAA (50 lM) in buffer A. The reference cuvette contained all components
except enzyme.
Figure 3 Interaction of MA with rSHMT and R401A SHMT
The spectra of rSHMT and R401A SHMT (1.2 mg/ml each) were recorded 0, 1 and 100 min
after addition of MA (250 lM) in buffer A separately.
425 nm was very rapid and could not be measured by con-
ventional spectroscopy. Figure 4(a) shows that when AAA
(50 lM) was mixed with rSHMT (10 lM), the absorbance at
425 nm decreased rapidly and the reaction was almost complete
in 75 ms. A pseudo-first-order rate constant of 44.6 s−" was
calculated. In contrast, the reaction of AAA with the R401A
SHMT was very slow and the disappearance of the absorbance
at 425 nm was monitored by conventional spectroscopy. A
pseudo-first-order rate constant of 8.15¬10−% s−" was calculated
at 50 lM AAA. The disappearance of the 425 nm absorbance on
addition of MA (250 lM), monitored with a stopped-flow
spectrophotometer, showed that the reaction was complete in 7.5
and 2.5 s for rSHMT and the mutant enzyme respectively (Figure
4b). The pseudo-first-order rate constants for rSHMTand R401A
SHMT were 0.2 and 1.72 s−" respectively.
Interaction of TSC with R401A SHMT
In the absence of Arg-401, the binding of the carboxy group of
the substrate cannot take place and consequently the formation
of the quinonoid intermediate (k
max
495 nm) cannot be moni-
tored. It has been shown previously that TSC generates a novel
quinonoid intermediate (k
max
464 nm) in its interaction with
SHMT [23]. It could be postulated that as TSC does not have a
carboxy group, the R401A SHMT should also generate this
intermediate if the other steps in the reaction are unaffected.
rSHMT and the mutant enzyme were capable of forming the
intermediates absorbing at 440 and 464 nm (results not shown).
The intermediates slowly decomposed to yield the PLP-thiosemi-
carbazone with an isosbestic point at 412 nm. It is interesting to
note that whereas the rate of formation of the intermediate is
similar, its decomposition is faster with the mutant as indicated
by rate constants of 0.036 min−", 0.085 min−" for rSHMT and the
mutant enzyme respectively.
Stability of R401A SHMT
We have shown earlier that PLP has a role in maintaining the
oligomeric structure of SHMT ([36,37], and B. Venkatesha,
J. B. Udgaonkar, N. Appaji Rao and H. S. Savithri (unpublished
work). Because R401A SHMT has a higher absorbance at
425 nm, it might also be more stable than rSHMT. To test this
possibility, the apoenzymes of R401A SHMT and rSHMT were
prepared by reaction with hydroxylamine rather than the more
conventional method of reaction with d-alanine or l-cysteine as
the mutant enzyme was unable to interact with these compounds
efficiently. The oligomeric status of the holoenzyme, as shown
in Table 1, was essentially tetrameric. The freshly prepared
apoenzyme of rSHMT eluted as a mixture of tetramer (60%)
and dimer (40%), whereas the apoenzyme of R401A SHMT
was mostly in the tetrameric form (more than 90%). Both
apoenzymes could be reconstituted to holoenzymes as monitored
by the regaining of 425 nm absorbance and visible CD. The
oligomeric structure of the reconstituted rSHMT was still a
mixture of tetramer and dimer (75% and 25% respectively). In
contrast, the reconstituted R401A SHMT was eluted as a single
symmetrical peak of tetramer with barely detectable amounts of
dimer. The apoenzyme of rSHMT stored at 4 °C for 48 h (after
dialysis) was present predominantly as a dimer (more than 75%)
(Table 1). On addition of PLP, only 5% of the dimer could
be converted to tetramer. Unlike rSHMT, the R401A SHMT
apoenzyme was present predominantly as a tetramer even after
48 h and it could be reconstituted to a holotetramer almost
completely (Table 1). These results indicate that R401A SHMT
apoenzyme was more stable than rSHMT.
The stability of the enzyme can also be monitored by deter-
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Figure 4 Rapid-reaction kinetics of interaction AAA and MA
rSHMT (10 lM) and AAA (50 lM) were mixed in a Biologic Stopped Flow Module and the decrease in absorbance at 425 nm was monitored. The increase in potential (mV) as a function of
time (s) is shown in (a). Similarly the interaction of rSHMT (10 lM) and R401A SHMT (10 lM) with MA (250 lM) is shown in (b). The experimental and curve-fitted curves are shown as broken
and dotted lines respectively.
Table 1 Oligomeric status of R401A SHMT holoenzyme, apoenzyme and
reconstituted holoenzyme
Proportion in oligomeric form (%)
rSHMT R401A SHMT
Enzyme Form Day 1 Day 3 Day 1 Day 3
Holoenzyme Tetramer 100 100 100 100
Dimer 0 0 0 0
Apoenzyme Tetramer 60 ! 25 " 90 " 80
Dimer 40 " 75 ! 10 ! 20
Reconstituted holoenzyme Tetramer 75 ! 30 " 98 " 90
Dimer 25 " 70 – ! 10
Table 2 Thermal stability of R401A SHMT in the presence of ligands
The apparent Tm values were determined from the first-derivative plots of the denaturation curves
(see the text for details).
Apparent Tm (°C)
Ligand (100 mM) rSHMT R401A SHMT
None 56 61
L-Serine 65 60
L-Serinamide 55 58
Glycine 58 58
D-Alanine 56 60
mining the apparent melting temperature (T
m
) values. It can be
seen from Table 2 that R401A SHMT had an apparent T
m
of
61³1 °C, compared with 56³1 °C for rSHMT. The addition
of serine enhanced the apparent T
m
of rSHMT from 56³1 to
64³1 °C, whereas this enhancement was not observed with the
mutant enzyme. Other ligands such as glycine, d-alanine and
serinamide also did not change the apparent T
m
values.
DISCUSSION
It has been suggested from model studies that Arg residues are
convenient anchors for carboxy groups of several substrates and
the formation of the ion pair provides the necessary chemical pull
to facilitate catalysis [38]. Mutation of these active-site Arg
residues results in the inability of substrates containing carboxy
groups to bind to the enzyme. An approach to the study of
interactions at the active site especially of such inactive mutants
is by the use of substrate analogues and inhibitors [11]. The
R401A mutation of SHMT resulted in a marked decrease in
the enzyme activity by 30000-fold with serine as the substrate.
The rate constant for the interaction of AAA with R401A mutant
enzyme was 1}50000 that of rSHMT. The decrease in the rate
constant was similar to the decrease in the specific activity
observed for R401A SHMT. However, the interaction of MA,
which lacks the carboxy group, was 9-fold faster with the mutant
enzyme than with rSHMT. TSC interacted with rSHMT and the
mutant enzyme, generating similar quinonoid intermediates. The
decomposition of this quinonoid intermediate to PLP-thiosemi-
carbazone was 3.5-fold faster in the case of mutant enzyme
compared to rSHMT. These results suggest that the Arg-401
residue has a role in the interaction of the enzyme with the
substrate carboxy group. The enhanced reactivity of the mutant
with the ligands lacking a carboxy group could be due to the
removal of the constraints imposed by the positive charge of the
Arg residue.
The results presented in Table 1 clearly indicate that R401A
SHMT apoenzyme was more stable as a tetramer than rSHMT.
A plausible explanation for the increased stability is that the
mutation of the Arg residue could have removed the charge
repulsion between subunits, resulting in more stable tetramers.
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The increased stability of the mutant was also reflected in the
higher apparent T
m
(Table 2) and more tightly bound cofactor
than in rSHMT. It has previously been suggested that the
increase in T
m
on the addition of the substrate serine results in
the conversion of the enzyme from an ‘open’ to ‘closed’ form
[39]. It was shown in the E. coli SHMT R363A mutant that the
rate of cleavage of l-serine ethyl ester and l-serinamide was
lower than expected, being only about 0.1% of the wild-type
enzyme with serine as a substrate [12]. These results suggested
that Arg-363 might have additional roles other than forming a
tight ion pair with the substrate’s carboxy group. It was suggested
that R363A mutant enzyme might be in an ‘open’ form owing to
the absence of an enhanced T
m
with substrate (serine or serina-
mide) and its ability to catalyse the transamination of d-alanine
methyl ester [12]. Similarly, the addition of serine or serinamide
did not result in a further increase in apparent T
m
for R401A
SHMT. These results suggest that the mutant enzyme did not
undergo the ‘open’ to ‘closed’ conformational change on
addition of these ligands and that the increased stability of
R401A could be the result of enhanced subunit interactions in
the ‘open’ form. In other words, Arg-401 has a role not only in
providing the positive charge for the formation of an ion pair
with the substrate’s carboxy group but also in maintaining the
conformational flexibility of the enzyme.
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